Roivant Sciences Ltd. (ROIV)
Key Takeaways from Roivant Sciences Ltd. 2025 10-K:
• Business Model & Vant Structure: Roivant spins out focused subsidiaries (Vants) around drug candidates/technologies, aligning incentives with Vant equity and leadership teams.
• Diversified Pipeline: Late-stage assets include brepocitinib (Ph...